Nano-X Imaging (NNOX) Other Non-Current Assets (2019 - 2026)
Nano-X Imaging (NNOX) posted quarterly Other Non-Current Assets of $2.4 million for Q1 2026, up 34.17% year-on-year from $1.8 million in Q1 2025, and up 47.49% on a QoQ basis from $1.6 million in Q4 2025.
Nano-X Imaging (NNOX) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Other Non-Current Assets for 8 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Assets rose 34.17% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 34.17% YoY) and the FY2025 annual result came in at $1.6 million, down 83.68% from the prior year.
- Other Non-Current Assets advanced to $2.4 million in Q1 2026 per NNOX's latest filing, from $1.6 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for NNOX reached as high as $124.0 million in Q1 2022 and fell as low as $63000.0 in Q2 2023.
- A 5-year average of $20.2 million and a median of $1.9 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 40689.47% — and 2023, when it plunged 99.95%.
- Year by year, Other Non-Current Assets stood at $2.9 million in 2022, then retreated by 24.56% to $2.2 million in 2023, then jumped by 362.32% to $10.0 million in 2024, then sank by 83.68% to $1.6 million in 2025, then soared by 47.49% to $2.4 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.4 million, $1.6 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Sep 30, 2023 | 353,000.00 |
| Jun 30, 2023 | 63,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Dec 31, 2022 | 2.87 Mn |
| Sep 30, 2022 | 65.00 Mn |
| Jun 30, 2022 | 124.00 Mn |
| Mar 31, 2022 | 124.00 Mn |
| Dec 31, 2021 | 127,000.00 |
| Sep 30, 2021 | 4.71 Mn |
| Jun 30, 2021 | 656,000.00 |